AlphaMark Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $55K | Sell |
150
-25
| -14% | -$10.5K | 0.02% | 236 |
|
|
2024
Q3 | $91K | Hold |
175
| – | – | 0.03% | 285 |
|
|
2024
Q2 | $95K | Sell |
175
-30
| -15% | -$15.9K | 0.03% | 284 |
|
|
2024
Q1 | $106K | Hold |
205
| – | – | 0.04% | 271 |
|
|
2023
Q4 | $97K | Hold |
205
| – | – | 0.04% | 274 |
|
|
2023
Q3 | $89K | Hold |
205
| – | – | 0.04% | 266 |
|
|
2023
Q2 | $91K | Hold |
205
| – | – | 0.04% | 165 |
|
|
2023
Q1 | $94K | Hold |
205
| – | – | 0.04% | 169 |
|
|
2022
Q4 | $105K | Buy |
205
+30
| +17% | +$15.2K | 0.05% | 143 |
|
|
2022
Q3 | $79K | Hold |
175
| – | – | 0.04% | 169 |
|
|
2022
Q2 | $84K | Hold |
175
| – | – | 0.04% | 167 |
|
|
2022
Q1 | $86K | Hold |
175
| – | – | 0.03% | 188 |
|
|
2021
Q4 | $81K | Hold |
175
| – | – | 0.03% | 200 |
|
|
2021
Q3 | $65K | Hold |
175
| – | – | 0.02% | 214 |
|
|
2021
Q2 | $67K | Hold |
175
| – | – | 0.02% | 210 |
|
|
2021
Q1 | $63K | Sell |
175
-285
| -62% | -$91.7K | 0.02% | 212 |
|
|
2020
Q4 | $148K | Hold |
460
| – | – | 0.06% | 135 |
|
|
2020
Q3 | $124K | Hold |
460
| – | – | 0.05% | 134 |
|
|
2020
Q2 | $121K | Hold |
460
| – | – | 0.05% | 127 |
|
|
2020
Q1 | $104K | Hold |
460
| – | – | 0.06% | 119 |
|
|
2019
Q4 | $139K | Hold |
460
| – | – | 0.06% | 121 |
|
|
2019
Q3 | $110K | Sell |
460
-40
| -8% | -$11K | 0.05% | 141 |
|
|
2019
Q2 | $141K | Hold |
500
| – | – | 0.06% | 118 |
|
|
2019
Q1 | $143K | Hold |
500
| – | – | 0.06% | 113 |
|
|
2018
Q4 | $131K | Hold |
500
| – | – | 0.06% | 115 |
|
|
2018
Q3 | $137K | Hold |
500
| – | – | 0.06% | 149 |
|
|
2018
Q2 | $119K | Hold |
500
| – | – | 0.05% | 158 |
|
|
2018
Q1 | $110K | Hold |
500
| – | – | 0.05% | 156 |
|
|
2017
Q4 | $113K | Hold |
500
| – | – | 0.04% | 155 |
|
|
2017
Q3 | $95K | Hold |
500
| – | – | 0.04% | 152 |
|
|
2017
Q2 | $94K | Hold |
500
| – | – | 0.04% | 151 |
|
|
2017
Q1 | $83K | Hold |
500
| – | – | 0.04% | 152 |
|
|
2016
Q4 | $72K | Hold |
500
| – | – | 0.04% | 147 |
|
|
2016
Q3 | $63K | Hold |
500
| – | – | 0.03% | 132 |
|
|
2016
Q2 | $66K | Buy |
+500
| New | +$68.4K | 0.04% | 126 |
|
|
2016
Q1 | – | Sell |
-500
| Closed | -$70K | – | 318 |
|
|
2015
Q4 | $70K | Hold |
500
| – | – | 0.04% | 122 |
|
|
2015
Q3 | $70K | Hold |
500
| – | – | 0.04% | 114 |
|
|
2015
Q2 | $82K | Hold |
500
| – | – | 0.05% | 118 |
|
|
2015
Q1 | $77K | Hold |
500
| – | – | 0.04% | 122 |
|
|
2014
Q4 | $63K | Hold |
500
| – | – | 0.04% | 136 |
|
|
2014
Q3 | $60K | Hold |
500
| – | – | 0.04% | 137 |
|
|
2014
Q2 | $54K | Hold |
500
| – | – | 0.03% | 148 |
|
|
2014
Q1 | $50K | Hold |
500
| – | – | 0.03% | 147 |
|
|
2013
Q4 | $46K | Hold |
500
| – | – | 0.03% | 149 |
|
|
2013
Q3 | $42K | Hold |
500
| – | – | 0.03% | 159 |
|
|
2013
Q2 | $41K | Buy |
+500
| New | +$37.4K | 0.03% | 174 |
|
Other funds holding ELV
AlphaMark Advisors's ELV Position: Q4 2024 in Review
AlphaMark Advisors reduced its Elevance Health (ELV) stake by 14% in Q4 2024, selling an estimated $10.5K and leaving 150 shares worth $55K. The position accounts for 0.02% of the portfolio, ranked #236.
AlphaMark Advisors first reported a position in ELV in Q2 2013 and has held it in 46 quarters since. The position peaked at $148K in Q4 2020. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.
- AlphaMark Advisors held 150 shares of Elevance Health worth $55K as of Q4 2024.
- AlphaMark Advisors sold 25 Elevance Health shares in Q4 2024, an estimated $10.5K.
- Elevance Health made up 0.02% of AlphaMark Advisors's portfolio in Q4 2024, its #236 holding.
- AlphaMark Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 46 quarters since.
- AlphaMark Advisors's Elevance Health position peaked at $148K in Q4 2020.
- 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.
Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.